The portfolio maintains a sizable cost advantage over competitors, priced within the second-cheapest fee quintile among peers.
ARK Genomic Revolution ETF ARKG
Morningstar’s Analysis ARKG
Will ARKG outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 50.5
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Twist Bioscience Corp | 7.94 | 108.4 Mil | Healthcare |
CRISPR Therapeutics AG | 7.03 | 96.0 Mil | Healthcare |
Recursion Pharmaceuticals Inc Class A | 5.89 | 80.5 Mil | Healthcare |
CareDx Inc | 5.66 | 77.3 Mil | Healthcare |
Arcturus Therapeutics Holdings Inc | 4.84 | 66.1 Mil | Healthcare |
Intellia Therapeutics Inc | 3.96 | 54.1 Mil | Healthcare |
Moderna Inc | 3.92 | 53.6 Mil | Healthcare |
Schrodinger Inc Ordinary Shares | 3.91 | 53.5 Mil | Healthcare |
Beam Therapeutics Inc | 3.70 | 50.5 Mil | Healthcare |
Ionis Pharmaceuticals Inc | 3.65 | 49.9 Mil | Healthcare |